Cargando…
Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
Aberrant NLRP3 inflammasome activation contributes to the development of endotoxemia. The importance of negative regulation of NLRP3 inflammasomes remains poorly understood. Here, we show that the E3 ubiquitin ligase Cbl-b is essential for preventing endotoxemia induced by a sub-lethal dose of LPS v...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144527/ https://www.ncbi.nlm.nih.gov/pubmed/31999304 http://dx.doi.org/10.1084/jem.20182091 |
_version_ | 1783519851478777856 |
---|---|
author | Tang, Juan Tu, Sha Lin, Guoxin Guo, Hui Yan, Chengkai Liu, Qingjun Huang, Ling Tang, Na Xiao, Yizhi Pope, R. Marshall Rajaram, Murugesan V.S. Amer, Amal O. Ahmer, Brian M. Gunn, John S. Wozniak, Daniel J. Tao, Lijian Coppola, Vincenzo Zhang, Liwen Langdon, Wallace Y. Torrelles, Jordi B. Lipkowitz, Stanley Zhang, Jian |
author_facet | Tang, Juan Tu, Sha Lin, Guoxin Guo, Hui Yan, Chengkai Liu, Qingjun Huang, Ling Tang, Na Xiao, Yizhi Pope, R. Marshall Rajaram, Murugesan V.S. Amer, Amal O. Ahmer, Brian M. Gunn, John S. Wozniak, Daniel J. Tao, Lijian Coppola, Vincenzo Zhang, Liwen Langdon, Wallace Y. Torrelles, Jordi B. Lipkowitz, Stanley Zhang, Jian |
author_sort | Tang, Juan |
collection | PubMed |
description | Aberrant NLRP3 inflammasome activation contributes to the development of endotoxemia. The importance of negative regulation of NLRP3 inflammasomes remains poorly understood. Here, we show that the E3 ubiquitin ligase Cbl-b is essential for preventing endotoxemia induced by a sub-lethal dose of LPS via a caspase-11/NLRP3–dependent manner. Further studies show that NLRP3 undergoes both K63- and K48-linked polyubiquitination. Cbl-b binds to the K63-ubiquitin chains attached to the NLRP3 leucine-rich repeat domain (LRR) via its ubiquitin-associated region (UBA) and then targets NLRP3 at K496 for K48-linked ubiquitination and proteasome-mediated degradation. We also identify RNF125 as an additional E3 ubiquitin ligase that initiates K63-linked ubiquitination of the NLRP3 LRR domain. Therefore, NLRP3 is sequentially ubiquitinated by K63- and K48-linked ubiquitination, thus keeping the NLRP3 inflammasomes in check and restraining endotoxemia. |
format | Online Article Text |
id | pubmed-7144527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71445272020-10-06 Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia Tang, Juan Tu, Sha Lin, Guoxin Guo, Hui Yan, Chengkai Liu, Qingjun Huang, Ling Tang, Na Xiao, Yizhi Pope, R. Marshall Rajaram, Murugesan V.S. Amer, Amal O. Ahmer, Brian M. Gunn, John S. Wozniak, Daniel J. Tao, Lijian Coppola, Vincenzo Zhang, Liwen Langdon, Wallace Y. Torrelles, Jordi B. Lipkowitz, Stanley Zhang, Jian J Exp Med Article Aberrant NLRP3 inflammasome activation contributes to the development of endotoxemia. The importance of negative regulation of NLRP3 inflammasomes remains poorly understood. Here, we show that the E3 ubiquitin ligase Cbl-b is essential for preventing endotoxemia induced by a sub-lethal dose of LPS via a caspase-11/NLRP3–dependent manner. Further studies show that NLRP3 undergoes both K63- and K48-linked polyubiquitination. Cbl-b binds to the K63-ubiquitin chains attached to the NLRP3 leucine-rich repeat domain (LRR) via its ubiquitin-associated region (UBA) and then targets NLRP3 at K496 for K48-linked ubiquitination and proteasome-mediated degradation. We also identify RNF125 as an additional E3 ubiquitin ligase that initiates K63-linked ubiquitination of the NLRP3 LRR domain. Therefore, NLRP3 is sequentially ubiquitinated by K63- and K48-linked ubiquitination, thus keeping the NLRP3 inflammasomes in check and restraining endotoxemia. Rockefeller University Press 2020-01-30 /pmc/articles/PMC7144527/ /pubmed/31999304 http://dx.doi.org/10.1084/jem.20182091 Text en © 2020 Tang et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Tang, Juan Tu, Sha Lin, Guoxin Guo, Hui Yan, Chengkai Liu, Qingjun Huang, Ling Tang, Na Xiao, Yizhi Pope, R. Marshall Rajaram, Murugesan V.S. Amer, Amal O. Ahmer, Brian M. Gunn, John S. Wozniak, Daniel J. Tao, Lijian Coppola, Vincenzo Zhang, Liwen Langdon, Wallace Y. Torrelles, Jordi B. Lipkowitz, Stanley Zhang, Jian Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia |
title | Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia |
title_full | Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia |
title_fullStr | Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia |
title_full_unstemmed | Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia |
title_short | Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia |
title_sort | sequential ubiquitination of nlrp3 by rnf125 and cbl-b limits inflammasome activation and endotoxemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144527/ https://www.ncbi.nlm.nih.gov/pubmed/31999304 http://dx.doi.org/10.1084/jem.20182091 |
work_keys_str_mv | AT tangjuan sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT tusha sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT linguoxin sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT guohui sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT yanchengkai sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT liuqingjun sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT huangling sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT tangna sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT xiaoyizhi sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT popermarshall sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT rajarammurugesanvs sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT ameramalo sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT ahmerbrianm sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT gunnjohns sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT wozniakdanielj sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT taolijian sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT coppolavincenzo sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT zhangliwen sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT langdonwallacey sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT torrellesjordib sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT lipkowitzstanley sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia AT zhangjian sequentialubiquitinationofnlrp3byrnf125andcblblimitsinflammasomeactivationandendotoxemia |